- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04779502
The Efficacy of Oregano Essential Oil in Reducing Oral Halitosis
March 2, 2021 updated by: MOHAMED SAEED M. ALI
The Efficacy of Oregano Essential Oil in Reducing Oral Halitosis :A Randomized Controlled Trial
the efficacy of commercially available oregano essential oil mouthwash in the reduction of oral halitosis was compared to chlorhexidine and distilled water and the results showed significant reduction of organoleptic tongue and floss scores and BANA test scores compared to placebo
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
the results showed that oregawash showed a comparable effect to chx in reducing oral halitosis
Study Type
Interventional
Enrollment (Actual)
54
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Rasafa
-
Baghdad, Rasafa, Iraq, 00964
- Univeristy of Baghdad
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 21 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Organoleptic score was >2 at baseline.
- Participants between 18-23 years of age.
- The subjects had no systemic disease and were not taking antibiotics or receiving other antimicrobial therapy.
- The subjects did not receive the same time treatment for their halitosis.
Exclusion Criteria:
- Smokers, alcoholics and drug addicts.
- Patients with periodontitis or pocket depth >6 mm.
- Patients taking drugs which induced xerostomia.
- Subjects consuming spicy food: garlic or onions two days before examination.
- Patients with orthodontic appliances or removable dentures.
- pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: oregano
oregawash mouthwash was used twice times daily for 7 days
|
mouthwash containing oregano essential oil
|
Placebo Comparator: placebo
distilled water was used twice times daily for 7 days
|
distilled water
Other Names:
|
Active Comparator: chlorhexidine
Corsodyl with 0.2%CHX mouthwash was used twice times daily for 7 days
|
0.2% chlorhexidine mouthwash
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
organoleptic tongue and floss scores
Time Frame: 9 month
|
organoleptic measuements
|
9 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
BANA test
Time Frame: 9 month
|
chair side BANA test
|
9 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: mohamed s albana, director, Univeristy of Baghdad
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 12, 2020
Primary Completion (Actual)
November 15, 2020
Study Completion (Actual)
November 17, 2020
Study Registration Dates
First Submitted
February 27, 2021
First Submitted That Met QC Criteria
February 27, 2021
First Posted (Actual)
March 3, 2021
Study Record Updates
Last Update Posted (Actual)
March 4, 2021
Last Update Submitted That Met QC Criteria
March 2, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 131619
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Halitosis
-
Hadassah Medical OrganizationCompleted
-
Semmelweis UniversityNot yet recruiting
-
University of North Carolina, Chapel HillColgate PalmoliveCompletedHalitosisUnited States
-
Novozymes A/SCompleted
-
Riyadh Colleges of Dentistry and PharmacyUnknown
-
Cairo UniversityUnknown
-
Universitaire Ziekenhuizen KU LeuvenGaba International AGUnknown
-
Okayama UniversityCompleted
-
Tokyo Medical and Dental UniversityCompleted